The phase transfer method was applied to perform the nucleophilic substitution of 2,6-dichloropurines by modified arylalkyl alcohol or phenols. Since under these conditions only the 6-halogen is exchanged, this method gives 2-chloro-6-aryloxy-and 2-chloro-6-arylalkoxypurines. 2-Chloro-6-benzylthiopurine was synthesized by alkylation of 2-chloro-6-thiopurine with benzyl bromide. The stereoisom ers of 2-chloro-6-(l-phenyl-l-ethoxy)purine were ob tained from R-and 5-enantiomers of sec.-phenylethylalcohol and 2,6-dichloropurine.
Introduction
Abbreviations: PNP, purine nucleoside phosphorylase; Ino, inosine; m7Guo, 7-methylguanosine; Hepes, (N-[2-hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid]); LB, Lineweaver-Burk; EH, Eadie-H ofstee; inhibition constant in uncompetitive or noncompetitive inhibiton models; K iu and K ic, inhibition constants in a mixed-type inhibition model; K m, Michaelis constant; vG , initial velocity; cQ , initial substrate concentration; I, inhibitor concentration; maximal velocity; IC50, concentra tion of an inhibitor causing 50% inhibition under experi mental conditions employed; nc, noncom petitive inhibi tion, uc, uncompetitive inhibition; U, enzyme activity unit; A. U. arbitrary units.
The ubiquitous enzyme purine nucleoside phos phorylase (PNP, E. C. 2.4.2.I.) catalyzes the re versible phosphorolysis of purine nucleosides, as follows:
The "high-molecular mass" hexameric enzymes, found in some bacteria (e.g. E. coli, S. typhimurium ), have a broad specificity towards purines ß-purine nucleoside + orthophosphate purine base + a-D -pentose-l-phosphate.
0939-5075/99/1200-1055 $ 06.00 © 1999 Verlag der Zeitschrift für Naturforschung, Tübingen • www.znaturforsch.com • D and purine nucleosides (Jensen and Nygaard, 1975; Doskocil and Holy, 1977; Bzowska et a l, 1990) , while the "low-molecular mass" trimeric, mainly mammalian, PNPs are specific in both binding and catalysis for 6-oxopurine nucleosides (Stoeckler, 1984; Bzowska et al., 1990; M ontgom ery, 1993) . Such differences in specificity between the hexameric and trimeric PNPs are in agreem ent with different architectures of the active centres and differences in specific interactions between the purine bases and the enzyme, observed in the crystal structures of E. coli. calf spleen and human erythrocyte phosphorylases (Mao et al., 1997 (Mao et al., , 1998 Koellner et al., 1997 Koellner et al., , 1998 Narayana et al., 1997) .
The PNP enzyme family is an im portant target for drug design (Stoeckler, 1984; Montgomery, 1993) . Potent inhibitors of mammalian phospho rylases may be useful in many circumstances, e.g. to prevent host-vmws-graft response in organ transplantation, to treat gout and to enhance ther apeutic effect of drugs that are purine nucleosides and therefore are cleaved by PNP before reaching their target. Selective inhibitors of the PNP en zyme present in parasites could prevent spread of parasitic infection. Finally, the E. coli PNP has re cently been shown to be useful in gene therapy of some types of tumours (Sorscher et al., 1994; Hughes et al., 1995) . The method is based on the fact that specificities of E. coli and human en zymes are different and therefore, in contrast to the human PNP, the E. coli enzyme is capable to convert some nontoxic deoxyadenosine analogues to highly toxic adenine analogues. For example, the expression of E. coli PNP in fewer than 1 % of cells in human colonic carcinoma cell lines was found to be efficient enough to kill virtually all bystander cells after treatm ent with 6-methylpurine-2'-deoxyribofuranoside. These findings have opened new directions in studies of the E. coli PNP, which beforehand had been studied much less extensively than the phosphorylases isolated from mammals, and stimulated broad experim en tal research (e.g. Bzowska and Kazimierczuk, 1995 Recently we have shown that substitution of the base with chlorine at position C-2 m arkedly en hances the affinity of purine and of 7-deazapurine 1056 A. Bzow ska et nucleosides to E. coli PNP (Bzowska and Kazi mierczuk, 1995; Bzowska et al., 1998a) . We have also observed that 6-benzyloxy-2-chloro-9-ß-D-(2'-deoxyribofuranosyl)purine is a very good and se lective substrate of E. coli PNP and one of the most potent competitive inhibitors of inosine phosphorolysis with an inhibition constant Kj = 0.5 [i,M (Bzowska and Kazimierczuk, 1995) . There fore we decided to synthesize some purine ana logues of this inhibitor substituted at both crucial positions, namely a series of 6-aryloxy-2-chloropurines and 6-arylalkoxy-2-chloropurines, and to in vestigate their kinetic properties with hexameric E. coli PNP and with more sepcific trimeric PNP from Cellulomonas sp.
Materials and Methods

Materials
Inosine, 7-methylguanosine, adenine, guanine, hypoxanthine, ribose-l-phosphate, Hepes, and xanthine oxidase from buttermilk (1 U/mg) were from Sigma (St. Louis, Mo., USA). 2-Chloroadenine was synthesized according to Brown and Weliky (1958) . E. coli PNP (60 U/mg) was a kind gift of Dr. G. Koszalka (Wellcome Research Laborato ries, Research Triangle Park, NC, USA), and was purified by affinity chromatography to 104 U/mg as described elsewhere (Bzowska et al., 1998a) . Cellulomonas sp. PNP (8 U/mg) was from Toyobo Company (Japan) and was purified by ion-ex change chromatography as previously described (Wielgus-Kutrowska et al., 1998; Bzowska et al., 1998b) . All solutions were prepared with highquality MilliQ water.
One unit of PNP is the amount of enzyme that will cause phosphorolysis of one jx,mol of inosine to hypoxanthine and ribose-l-phosphate per min at 25 °C with 0.5 mM inosine and 50 mM Na-phosphate buffer pH 7.0 (see also section Enzym e ac tivity).
Ultraviolet spectroscopy was performed with a Kontron (Vienna, Austria) Uvikon 940 UV-VIS spectrophotom eter fitted with thermostatically controlled cell com partments and with the use of 2, 5 or 10 mm path length cuvettes. The concentra tions of substrates and inhibitors were determined spectrophotometrically from their molar extinc tion coefficients, which are listed in Table I for an alogues synthesized in this study, and were com-plied from literature for other substrates: e(260 nm) = 13 350 M_1cm _1 for adenine, e(264 nm) = 12 000 M-1cm-1 for 2-chloroadenine, s(260 nm) = 8 500 M_1cm_1 for m7Guo at pH 7, and e(249 nm) = 12 300 M_1cm _1 for inosine (D aw son et al., 1969) . Thin-layer chromatography was perform ed on silicagel plates with the solvent con sisting of chloroform-methanol 9:1 (by vol.). M elt ing points (uncorr.) were measured on a Boetius microscope hot storage (Radebeul, Germany). NM R spectra were recorded on Bruker AC 250 (Karlsruhe, Germany). M easurements of pH were carried out with Beckman pH-m eter equipped with a combination semimicro electrode and tem perature sensor. Gel filtration FPLC chrom atogra phy was carried out on Pharmacia LKB Biotech nology (Uppsala, Sweden) equipment.
For linear regression analysis of the kinetic data, the Cricket G raph program for the Macintosh com puter was used. For nonlinear regression analysis, the Leonora program (version 1.0) run on a PC com puter (A. Cornish-Bowden, 1995) was employed.
The phase transfer method was applied to per form the nucleophilic substitution of 2,6-dichloropurines by modified arylalkyl alcohols or phenols. Since under these conditions only the 6-halogen was exchanged, the method produces 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines. 6-Benzylthio-2-chloropurine was synthesized by alkylation of 2-chloro-6-thiopurine with benzyl bromide. The stereoisom ers of 2-chloro-6-(l-phenyl-lethoxy)purine were obtained from R-and S-enantiom ers of sec. -phenylethylalcohol and 2,6-dichloropurine. Structures of the 6-aryloxy-2-chloroand 6-arylalkoxy-2-chloro-analogues are pre sented in Figure 1 . The details of the synthetic pro cedures are given below. All new purine deriva tives were characterized by elemental analysis, melting points, TLC chromatography, UV and NM R spectra. The data are presented in Tables I  and II. Synthesis o f 6-aryloxy and 6-arylalkoxy 2-substituted purines A mixture of 6-chloro-2-substituted purine (2.5 mmol), finely powdered KOH (350 mg appro priate phenol or arylalkyl alcohol (5 mmol), tetra- butyl hydrosulfite (50 mg) and acetonitrile (2.5 ml) was vigorously stirred at 80 °C (oil bath) for 2 h. Then 3 ml of water was added and the mixture was neutralized by acetic acid. The precipitate formed after few h storage at low tem perature was filtered and crystallized from ethanol/water mixtures. The yields were 55-85% with respect to starting pu rine derivative. 
Synthesis o f 6-benzylthio-2-chloropurine
A solution of 2-chloro-6-thiopurine (370 mg, 2 mmol) and potassium carbonate (280 mg, 2 mmol) in 20 ml of a water/m ethanol mixture (7:3, v/v) was stirred at room tem perature. Benzyl chlo ride (285 ^1, 2.5 mmol) was added and the resulting solution was stirred overnight at room tem perature and finally neutralized with acetic acid. The precipi tate was separated and crystallized from 50% m eth anol. Light yellow needles (330 mg, 63%) with m.p. 236-239 °C were obtained.
E nzym e activity
The specific activity of purine nucleoside phosphorylase was measured spectrophotometrically with the use of Kalckar's method, where inosine was the variable substrate and the product (hypoxanthine) oxidized by xanthine oxidase to form uric acid (Kalckar, 1947; Stoeckler et al., 1978) . One unit of phosphorylase is defined as the am ount of enzyme that will cause phosphorolysis of one (j,mol of inosine to hypoxanthine and ribose-1-phosphate per min at 25 °C with 0.5 mM in osine and 50 mM sodium phosphate buffer pH 7.0.
Enzym atic procedures, determination o f IC50 and selectivity o f inhibition
In preliminary experiments, all compounds were tested for inhibitory activity vs. the E. coli PNP with 7-methylguanosine as the variable substrate (Kulikowska et al., 1986; Bzowska et al., 1990) , and in conditions of saturation with the second sub strate of phosphorolysis, i.e. with orthophosphate. The inhibition was measured at 25 °C, in a pH 7.0 and 50 mM sodium phosphate buffer, at the initial substrate concentration cQ = 20 ^im, and for at least three different inhibitor concentrations. The phos phorolysis was monitored spectrophotometrically at 260 nm (Kulikowska et al., 1986) . The initial velocity of the phosphorolysis was calculated by linear regression of absorbance vs. time. The IC50 values were calculated from plots of the inhibition ratio (Vi/v0) vs. inhibitor concentration I, where vQ is the initial velocity of phosphorolysis with no in hibitor added and v; is the initial velocity in the presence of an analogue. The type of inhibition and the inhibition constants Kiu and Kic were then determ ined only for analogues showing good in hibitory properties in the initial screening (IC50 < 10 jam) with exception of adenine for which for the purpose of comparison full analysis was done re gardless its known poor inhibitory properties (Jen sen, 1976; Doskocil and Holy, 1977) .
Compunds with IC50 < 10 (im were tested also for inhibiton vs. the Cellulomonas PNP. The exper imental conditions were as descibed above for the E. coli PNP. Concentrations of the analogues em ployed in this case were at least ten fold higher that IC50 values determined for the E. coli PNP.
Enzym atic procedures -inhibition type and inhibition constants
For the most potent inhibitors, i.e. those with IC50 < 10 [i m , the type of inhibition and the inhibi tion constants were determ ined by the initial velocity method with 7-methylguanosine as the variable substrate (see above). The initial veloci ties v0, and V; m easured in the absence and in the presence of an inhibitor, correspondingly, were ob tained from linear regression of absorbance (^Qbs = 260 nm for m7G uo) vs. time. At least five initial substrate concentrations (in the range 5-100 |j,m ), and typically four or five different inhibitor con centrations (including no inhibitor added) were analyzed, so the typical data set consisted of initial velocity values m easured for 20 or 25 combina tions of c0 and I. The measurem ents were con ducted twice for each pair (cQ , I).
A. Linear regression
To determ ine the inhibition type, the data were plotted in the form of Lineweaver-Burk (LB), 1/ vQ vs. l/cQ; Eadie-Hofstee (EH ), v0 vs. v0/c0 and Hanes, c0/v0 vs. cQ, plots (Keleti, 1986) . A linear regression analysis was performed. Replots of the slopes and y-intercepts of the LB plot vs. I were analyzed to classify the inhibition type according to Cleland (1963) . In case of doubts on the inhibi tion type, additional plots were analyzed and com pared with the literature (Keleti, 1986) , i.e. the Dixon, ) vs. c0, plots.
For adenine and 2-chloroadenine, the inhibition constants were determ ined with the use of the model of noncompetitive inhibition, as a mean of the values obtained as: the slope and y-intercept of the replots of the LB and Hanes plots, and the x-and y-intercepts of the replots of the EH plot vs. inhibitor concentration I (Keleti, 1986) . For all 2-chloro-6-aryloxy-and 2-chloro-6-arylalkoxypurines the uncompetitive inhibition model was used and the inhibition constants were determ ined as a mean of the values obtained from the replots of the LB, EH and Hanes plots vs. either the inhibi tor concentration I (the x-and y-intercepts of the LB plot and the slope of the Hanes plot), or the reciprocal of inhibitor concentration 1/1 (the x-intercept of the Hanes plot, the slope and y-in tercept of EH plot) (Keleti, 1986) .
All experimental data for inhibition of 7-methylguanosine phosphorolysis by 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines, and by adenine and 2-chloroadenine, were additionally analyzed with the use of the weighted leastsquares non-linear regression (Leonora numerical program, Cornish-Bowden, 1995) . Models of un competitive (Kic = oc, in Eqn. (1)) and mixed-type inhibition (Eqn. (1)) were com pared by analysis of variance. The data were finally fitted to the mixedtype inhibition model described by the following equation with two inhibition constants, Kiu and B. Nonlinear regression
The inhibition constants presented in Table III were determ ined by fitting equation (1) to the whole data set obtained for one analogue, i.e. for all triplets (v0, cQ , I).
Substrate properties
The direct spectrophotom etric m ethod was em ployed to study the substrate activity of the 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines in the reverse synthetic direction of the PNP-catalyzed reaction. The reaction mixture (1 ml volume, kept at 25 °C) contained 1 mM ribose-l-phosphate, 50 mM Hepes buffer pH 7.0, and a substrate in a concentration of approximately 100 ^im (or lower in the case of analogues 6-benylthio-2-chloro, 3, 6-(p-iodo-phenoxy), 2e, and 6-((/?)-l-phenyl-lethoxy, 4a, due to their poor solubility in water). The reaction was initiated by addition of the en zyme (0.1 [xg of E. coli PNP), and UV absorption spectra in the range 220-360 nm were recorded every 2 min until the reaction reached equilibrium. If the reaction seemed very slow in these condi tions, 2 [ig of PNP was added to 1 ml of the reac tion mixture after recording of several spectra. The natural substrates of the E. coli enzyme, ade nine and guanine, were used in control experi ments conducted in a similar way as described above.
The rates of synthesis were determ ined for three analogues: 6-methoxy-, 6-ethoxy-and 6-benzyloxy-2-chloropurines (5a, 5b and la), for which 2'-deoxyribonucleosides had already been synthe sized, and spectral data for them were available (Kazimierczuk et al., 1992; Bzowska and Kazimierczuk, 1995) . The absorbance at )\.obs was plotted vs. time and the initial velocity of the synthesis was calculated by linear regression of the initial linear portion of the plots A(t). The experimental condi tions were the following: cQ = 200 [.im (i.e. equal to Km, Jensen and Nygaard, 1975) , ?iobs = 260 nm and Ae = +1700 M-, cm -1 for adenine (Dawson et al., 1969) , c0 = 100 [xm, A ,obs = 249 nm, Ae = +5050 m-1 cm -1 for 2-chloro-6-methoxy (5a), c0 = 100 [tm, >tobs = 245 nm, Ae = +3400 M_1cm _1 for 2-chloro-6-ethoxypurine (5b), (Bzowska and Kazimierczuk, 1995) , and cQ = 60 ^im, Xobs = 250 nm, Ae = +3000 M-1cm _1 for 6-benzyloxy-2-chloropurine (la).
E nzym e stabilization pattern research
To determ ine the ligand-induced stabilization of the enzyme, the E.coli PNP was additionally puri fied with the use of gel filtration FPLC chrom atog raphy method (Superose 12, H R 10/30 column) in order to remove traces of phosphate. The residual phosphate could be present in the enzyme sample purified by the affinity chromatography because the phosphate buffer is used in this method to re move the enzyme from the affinity column (Bzow ska et al., 1998a). The column for the gel filtration was equilibrated and eluted (flow rate 0.4 ml m in-1) with 50 mM Hepes buffer pH 7 and 0.2 ml fractions each were collected.
In stabilization experiments the E.coli enzyme (0.056 mg/ml, 2.3 p,M in a total volume of 100 j.il) was incubated for 10 min at 56 °C in the absence (control experiment) and presence of the ligands. Before and after the heat treatm ent the specific activity of the enzyme was determined as de scribed above, i.e. with Ino as the variable sub strate (0.5 mM) at 50 mM phosphate pH 7.0 and 25 °C (see section Enzym e activity). The ligands were present at concentrations indicated in Ta ble IV. The heat treatment was conducted at pH 7.0 (50 mM Hepes buffer), i.e. close to the pH value optimal for the stability of the enzyme (Krenitsky et al., 1981) , and the same as used for all kinetic experiments. In some cases (see Ta ble IV) 5% M eOH was present in the incubation mixture. The addition of methanol was necessary in the case of experiments with 6-benzylthio-2-chloropurine because its solubility in water is very low. For this reason for other ligands the stabiliza tion patterns in the absence and presence of m eth anol were determ ined (see Table IV ). The stabili zation patterns are in principle similar in the absence and in the presence of 5% MeOH, al though the enzyme is slightly less stable in the lat ter case.
Results
Inhibition properties with Escherichia coli and Cellulomonas phosphorylases
The direct spectrophotom etric method with m7Guo as substrate was employed to study the in hibitory properties of the 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines. The most typical spectrophotom etric assay for the PNP enzyme, i.e. the method of Kalckar based on coupling of the PNP catalyzed reaction with the xanthine oxidase reaction (Kalckar 1947; Stoeckler et al., 1978) , is very sensitive to the presence of purine bases in the reaction mixture (because many of purine base analogues are inhibitors or substrates of xanthine oxidase), and therefore could not be employed in this study.
In preliminary experiments the IC50 value was determ ined for all the compounds vs. the E. coli PNP (see Table III ). All derivatives dem onstrated some inhibitory activity with the enzyme, although difference between the best inhibitor, 6-benzylthio-2-chloropurine, 3, IC50 = 0.5 |i m , and the one showing the weakest activity, 2-chloro-6-(2,4,6-trimethylphenoxy)purine, 2 g, IC50 >100 (im, was more than 2 orders of magnitude. However, all new analogues show more potent inhibitory activ ity than the two natural PNP substrates hypoxan- Table III thine and adenine (see Table III ). Two analogues that lack the 2-chloro substituent, i.e. 2-amino-6-benzyloxy-(6a) and 6-benzyloxy-2-trifluoromethylpurine (6b), have much higher IC50 than their corresponding 2-chloro counterpart (la) (see Ta  ble III) . The compounds showing IC50 < 10 [a m were tested also for inhibition vs. the Cellulomonas PNP. None of them caused detectable decrease of ^ the enzyme activity in a concentration of about ten fold higher than IC50 determ ined with the E. coli > enzyme. Cellulomonas PNP is a homotrimeric en zyme with molecular mass typical for the "low-mo lecular mass" PNPs. Therefore it may be con cluded that derivatives synthesized in this study are probably selective inhibitors of the "high-molecular mass" hexameric phosphorylases.
The compounds showing IC50 < 10 jam in the initial screening vs. the E. coli PNP were then ana lyzed more extensively to determ ine the inhibition type and inhibition constants (8 analogues, see Ta ble III). In addition, for the purpose of com pari son the inhibition by adenine and 2-chloroadenine were analyzed with the same methods.
The kinetic data were transform ed to the Lineweaver-Burk, Hanes of Eadie-Hofstee coordinates, and linear regression was perform ed. The uncom petitive type of inhibition was found to be in agreement with the experim ental data for all 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines, while the simple noncompetitive model de scribed the inhibition caused by adenine and 2-chloroadenine. The data for 2-chloro-6-(3-phenyll-propoxy)purine, lc and 2-chloroadenine, dis played as a Lineweaver-Burk plot of l/v0 vs. l/cQ , are shown in Figure 2A and 2B, respectively. In the case of inhibitor lc, a set of almost parallel lines were obtained, so the inhibition may be de scribed as uncompetitive. The inhibition constant obtained from the replot of slopes vs. I is K; = 1.1 |a m . Also other plots (Hanes, Eadie-Hofstee) of the same data set were in agreem ent with the un competitive inhibition type (data not shown), and the inhibition constant obtained as the mean form all replots is Kj = 1.4 ± 0.9 (.im . While similar plots (data not shown) were also obtained for other 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines, in some cases the independence of the slopes of the LB plot on I was not so clear. So for the new analogues synthesized in this study it may be 1/m7Guo concluded that linear regression analysis of the data suggests the uncompetitive model of inhibi tion, although errors of Kj determ ination are high (see below) and the mixed-inhibition type with a much higher value of the second inhibition con stant cannot be ruled out.
The inhibition constants obtained from linear regression analysis are in agreement with the p re liminary screening results (IC50, see Table III) , and show the following order of influence of the aryloxy and arylalkoxy substituents on the inhibitory activity vs. E. coli PNP of the following 6-substituetd-2-chloropurines: 6-benzylthio (3) Kj = 0.45 ± 0.09 [ a m , 6-benzyloxy (la) Kj = 1.0 ± 0.5 j a m , 6-(2-phenyl-l-ethoxy) (lb ) K; = 1.3 ± 0.6 [im, 6-(3-phenyl-l-propoxy) (lc) K; = 1.4 ± 1.0 [a m , 6-ethoxy (5b) Kj = 1.9 ± 0.4 [i m , 6-((/?)-l-phenyl-l-ethoxy) (4a) K; = 2.3 ± 0.8 [am, 6-methoxy (5a) K; = 7.7 ± 1.3 [i m and ö-(p-iodophenoxy) (2e) K; = 10.2 ± 2.8 [.i m . By constrast, S-stereoisomer of compound 4a, showed only very weak inhibiton in comparison with its 7?-counteropart (see Table III ). It should be noted that Kj values obtained by linear regres sion assuming uncompetitive inhibition type are similar to Kiu values (see Table III ) determ ined finaly using the equation for the mixed type inhibi tion (Eqn. (1)) which was found to be a better model (see next section).
In contrast, for inhibition caused by 2-chloroad enine, both the slopes and the y-intercepts of the LB plot vary with I (see Fig. 2B ). The inhibition constants obtained from replots of the slopes and y-intercepts are Kjslope = 2.2 jam and Ki,ntercept = 3.6 [i m , respectively. Also Hanes and EadieHofstee plots obtained for the same data set agree in first approximation with the pure noncompeti tive inhibition; the inhibition constant obtained with the assumption of the noncompetitive type of inhibition was Kj = 2.8 ± 0.5 [im. The same type of dependence was obtained for inhibition caused by adenine (data not shown), although the value of inhibition constant was much higher, Kj = 197 ± 16 [IM .
Inhibition constants and type o f inhibition
The data sets that were initially analyzed as de scribed above were then analyzed once again with the use of the weighted non-linear regression least squares method (the Leonora numerical program, Cornish-Bowden, 1995) . The main objective of this analysis was model discrimination between the un competitive and mixed types of inhibition (see Methods). On the basis of the F-values associated with the introduction of the fourth param eter (Kic) to the three param eter model describing the un competitive inhibition (Kiu, Km and Vmax), it was concluded in the case of all 6-aryloxy-2-chloroand 6-arylalkoxy-2-chloropurines studied that the introduction of Kic makes significant improve ments to the fits, so the mixed-type inhibition is the proper model to describe the experimental data. For example, in Figs. 3A and 3B the data sets for 2-chloro-6-(3-phenyl-l-propoxy)purine, lc and 2-chloroadeninie are shown in a form of direct plot vQ vs. cQ , and the lines fitted with Eqn. (1) to the whole data set are included.
The inhibition constants determ ined by fitting Eqn. (1) (see Methods) are listed in Table III . How ever, it should be noted that for all 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines studied K1U is much smaller than Kic (sometimes even by an order of magnitude), so in the first approxima tion the inhibition may be described by the un competitive model, as it was done in the previous section. This discrepancy between the two inhibi tion constants was not observed for inhibition caused by adenine and 2-chloroadenine. for which values for Kiu and Kic were found to be almost identical (see Table III ), and the inhibition at first sight appeared to be of a simple noncompetitive type.
Substrate properties
All derivatives synthesized in this study are purines-base analogues and therefore in principle may be substrates in the reverse synthetic direc tion of the reaction catalyzed by PNP (see Intro duction, reaction scheme). Therefore their sub strate activity was studied. In the proposed mechanism of the reaction catalyzed by E. coli PNP, ribose-l-phosphate is the first substrate to add to the free enzyme in a synthetic direction and purine bases add to the binary complex between the enzyme and ribose-l-phosphate (Jensen, 1976) , so the conditions with the ribose-1-phos phate present in a saturation concentration (1 mM) were employed.
Three analogues 6-methoxy-, 6-ethoxy-and 6-benzyloxy-2-chloropurines (5a, 5b and la) for which 2'-deoxyribonucleosides have already been synthesized and described in the literature (Kazimierczuk et al., 1992; Bzowska and Kazimierczuk, 1995) were chosen for more detailed studies. For all three purine-base analogues, changes in UV spectra after addition of the E. coli PNP were con sistent with formation of a corresponding nucleo side, i.e. increase of absorbance in the region of 260-nm peak, a decrease of absorbance of the long-wavelength side of the peak, and small changes in A .max were observed. The initial rates of the synthesis reaction were; 9% for 6-ethoxy-, 5b, 4% for 6-methoxy-, 5a, and 2% for 6-bezyloxy-2-chloropurine, 3, when compared with the experi mental rate for adenine taken as 50% (cG for ade nine was equal to Km, so the measured rate may be assumed to be 50% of Vmax). These values should be treated only as a rough approximation of the true rates since: (i) the extinction coeffi cients of 2'-deoxyribonucleosides, not of ribonucleosides, were used for calculations, (ii) a full ki netic analysis for the analogues 3, 5a and 5b was not carried out, so the saturation conditions were not necessarily achieved, and the measured rates are not neccesarily equal to Vmax.
The overall changes in the UV spectra of other purine-base analogues, for which spectral proper ties for the corresponding nucleosides are not known, were similar as those observed for ana logues 5a, 5b and la. Thus it may be concluded that all 6-aryloxy-and 6-arylalkoxy-2-chloropurines studied are substrates of the E. coli PNP in the reverse synthetic direction.
Ligand stabilization pattern
The effects of 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines on the thermal stability of E. coli PNP were established to determ ine the type of complexes with the PNP enzyme that the new analogues are able to form (binary or ternary com plexes). Natural substrates (purine nucleosides, purine bases, phosphate and ribose-l-phosphate) were used in control experiments. By kinetic analysis, binding studies and stabilization pattern it has already been shown that purine nucleosides (inosine and adenosine), phosphate, and ribose-lphosphate are able to form binary complexes with the free enzyme, while the purine bases are proba bly not capable to bind to the free enzyme and they form ternary complexes only: a catalytical one with enzym e/ribose-l-phosphate (see Intro duction, the reaction scheme), and a dead-end complex with enzym e/orthophosphate (Jensen and Nygaard, 1975; Jensen, 1976; Krenitsky and Tuttle, 1982) . Table IV presents data obtained for 6-benzyloxy-2-chloropurine, la, and 6-benzylthio-2-chloropurine, 3. Similar data (not shown) were ob tained for other 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines. The concentrations of ligands employed were chosen on the basis of the inhibition constants of the analogues obtained in the previous section (see Table III ). The stabiliza tion pattern determ ined here is similar to the pattern described by Krenitsky and Tuttle (1982) : the purine bases are the only substrate of four that in principle are incapable of effectively stabilize the enzyme in the absence of other substrates. However, the combination of purine base and phosphate resulted in a stabilization (see Ta  ble IV) . Similar data were obtained for 2-chloroadenine that had been chosen as an additional control, because its inhibition constant is similar to those found for many 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines (see Table III ). It should be noted finally, that adenine present in 4 mM concentration, by contrast to other purine bases, provides some protection for the E. coli en zyme (22% of activity remains after the heat treat ment, see Table IV) . It was not possible to check if presence of higher concentration of 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines is able to stabilize the enzyme due to poor solubility of these analogues in water. Hence, it may be concluded that many 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines, similarly as the natural purine bases, are able to form the dead-end ternary complex with the E. coli enzyme and orthophosphate. However, bind ing in the case of these analogues, as well as in the case of 2-chloroadenine, is much stronger than observed for the natural purine bases, because lower concentration of ligands is enough to par tially stabilize the enzyme.
Discussion
All new analogues synthesized in this study were shown to be selective inhibitors of the hexameric "high-molecular mass" PNP isolated from E. coli. They were inactive vs. trimeric enzyme from Cellulomonas sp., although the later enzyme is less specific than typical trimeric "low-molecular mass" PNPs (Wielgus-Kutrowska et al., 1998).
The inhibitory properties of many 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines with E. coli PNP markedly depend on the kind of sub stituents placed at positions 2 and 6 of the pu rine base. In agreem ent with the previous finding (Bzowska and Kazimierczuk, 1995; Bzowska et al., 1998a) , a substitution of the purine base with chlorine at position C-2 results in analogues with the inhibitory activity at least 2 orders of magni tude higher than the activity of their counter parts with no substituent (e.g. 2-chloroadenine as compared to adenine) or with other substituents at this position (e.g. 6-benzyloxy-2-chloropurine, la, as compared with 2-amino-6-benzyloxy, 6a, and 6-benzyloxy-2-trifluoromethylpurine, 6b). In E. coli PNP the base binding site is largely ex posed to solvent and for most purines only a weak C(8)-H hydrogen bond to Ser90 and un specific aromatic-aromatic interactions of the pu rine base with Phel59/Tyrl60 are observed (Mao et a l, 1997; Koellner et al., 1998). The influence of the 2-chloro substitution could probably be explained as an enhancem ent of the aromaticaromatic interactions between the purine ring and Phel59/Tyrl60 caused by changes of the electronic properties of the purine base intro duced by the substituent.
The influence of the additional substituent placed at position 6 is in agreem ent with the re sults reported earlier (Bzowska and Kazimierczuk, 1995; Bzowska et al., 1998a) . From the series of derivatives synthesized in the present study, benzyloxy and benzylthio analoguess (la , 3) are the most potent inhibitors of the E. coli enzyme. The uncompetitive inhibition constants, Kiu are 0.59 and 0.37 |.i m , respectively. Therefore these two an alogues, together with the neutral form of 6-methylformycin A and 6-benzyloxy-2-chloro-9-ß-D-(2'-deoxyribofuranosyl)purine, with the inhibi tion constants 0.3 and 0.5 j a m , respectively, are the best inhibitors of the E. coli PNP reported up to now. It should be stressed, however, that the deriv atives synthesized in the present study are the only purine base analogues with affinity to the E. coli enzyme better than 1 (.i m .
Somehow surprising results were obtained dur ing determ ination of the inhibition constants for the analogues synthesized in the present study. In contrast to the noncompetitive inhibition of adenine reported by Jensen (1976) , for 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines at first sight inhibition seemed to be uncompetitive. However, a detailed analysis of the data for these analogues, and for inhibition by adenine and 2-chloroadenine measured in a control ex periments, revealed that the reason of this discrepancy is the fact that the inhibition type is neither noncompetitive nor uncompetitive but mixed. Therefore two inhibition constants have to be introduced in all cases to describe the inhibition properly (Eqn. (1), see Methods). But in the case of adenine and 2-chloroadenine the two constants, Kiu and Kic, have almost the same value (although the difference between the in hibitory activities of the analogues is two orders of magnitude, see Table III ), so the inhibition appears noncompetitive. By contrast, for all 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines Kiu is several-fold lower than Kic, so the inhibition seems to be uncompetitive.
It has been shown here that according to the reaction mechanism proposed by Jensen and Nygaard (1975) , 6-aryloxy-2-chloro-and 6-arylalkoxy-2-chloropurines are able to form similar ter nary complexes with the E. coli PNP as the natural substrates, i.e. catalytical complex with the enzyme/ribose-l-phosphate, and dead-end complex with the enzyme/orthophosphate. But it cannot be unequivocally concluded if these analogues are able to bind to the free enzyme. It should be noted that the same problem exists also in the case of the natural substrate adenine, which in a high con centration (4 mM) is able to partially but signifi cantly protect the enzyme from thermal inactiva tion even in the absence of phosphate (see Table IV ). This result does not agree with the pro posed reaction mechanism for the E. coli PNP in which the purine bases are not able to bind to the free enzyme (Jensen and Nygaard, 1975) . One ex planation may be traces of phosphate in the incu bation mixture. A nother may be to assume that the proposed mechanism is an oversimplification of the true mechanism and that the purine bases have affinity, though very weak, to the free en zyme, and therefore are able to form binary com plexes. The first explanation seems to be unlikely since traces of phosphate should result also in the stabilization by 6-benzylthio-and 6-benzyloxy-2-chloropurines, which was not observed (see Ta  ble IV) . This problem could probably be resolved by a detailed kinetic analysis of the substrate and inhibitor properties of the purine bases in the syn thetic and phosphorolytic directions of the PNPcatalyzed reaction or by methods that allow to de termine the binding constants for possible com plexes (binary and ternary ones) directly. Such studies, performed mainly with the use of fluores cence spectroscopy methods, are now underway.
